Stock listing
Novavax, Inc.
- Ticker
- NASDAQ:NVAX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Novavax, Inc.
Novavax, Inc. is a publicly traded company listed under the ticker NVAX, operating in the American market. Novavax focuses on developing innovative vaccines to address various infectious diseases.
Latest news from Novavax, Inc.
Novavax to Participate in September Investor Conferences
Sep 2, 2026
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
Aug 28, 2026
Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
Aug 6, 2026
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
Jul 30, 2026